AMSA Scorecard Provides Useful Conflicts of Interest Tool For Industry Compliance Professionals Read more
Transparency International Addresses “Corruption in the Pharmaceuticals and Healthcare Sector” Read more
OIG Releases Mid-Year 2015 Work Plan, Includes New Provisions Related to Open Payments Oversight and Scrutiny into Clinical Laboratory Payments Read more
Massachusetts Introduces Drug Cost Transparency Bill That Would Cap Prices For Certain Products; North Carolina and Pennsylvania Also Introduce Bills Requiring Drug Cost Reports Read more
Oregon Introduces Pharmaceutical Cost Transparency Bill; PhRMA and BIO Outline Serious Concerns To Oregon State Legislature During Public Hearing Read more